Market closed· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Medtronic plc (NYSE:MDT) has been a bit of a slow burner. The company has a huge medical-device business and a dependable dividend, but growth has been difficult to find over the past few years. For investors, that has made Medtronic more of an income and stability play than a stock with much excitement around it. […]
BillionToOne’s updated analyst narrative now centers on a fresh Fair Value price target of US$128.57, compared with the prior US$122.14 level in this framework. Recent Street research links this adjustment to enthusiasm around the company’s technology and market reach, while also reflecting new questions on reimbursement risk and long term pricing power. As you read on, you will see how these moving pieces shape the evolving story around BillionToOne and what to watch as the narrative changes...
Greek inflation at 5.1% and energy prices jumping 25.4% year over year have turned the country’s power sector into a pressure cooker, with households squeezed and producers holding rare pricing power. That kind of stress can reset winners and laggards faster than many investors react. This article breaks down three Greek energy producers and utilities exposed to these shocks so you can judge where risk and potential opportunity might lie. The stocks covered below are only a sample, with the...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.